Caspase-activated phosphoinositide binding by CNT-1 promotes apoptosis by inhibiting the AKT pathway

Nature Structural and Molecular Biology

Volumn 21, Issue 12, 2014, Pages 1082-1090

  Nakagawa, Akihisa ^a   Sullivan, Kelly D ^a   Xue, Ding ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CONCENTRATIVE NUCLEOSIDE TRANSPORTER 1; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PROTEIN KINASE B; CAENORHABDITIS ELEGANS PROTEIN; CED-3 PROTEIN, C ELEGANS; CNT-1 PROTEIN, C ELEGANS; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5-TRIPHOSPHATE; POLYPHOSPHOINOSITIDE; PROTEIN BINDING;

APOPTOSIS; ARTICLE; CAENORHABDITIS ELEGANS; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME SUBSTRATE; GROWTH INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; ANIMAL; BINDING SITE; CHEMISTRY; CYTOLOGY; METABOLISM; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

CAENORHABDITIS ELEGANS;

ANIMALS; APOPTOSIS; BINDING SITES; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; CASPASES; GTPASE-ACTIVATING PROTEINS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHATIDYLINOSITOL PHOSPHATES; PROTEIN BINDING; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 84926650166     PISSN: 15459993     EISSN: 15459985     Source Type: Journal    
DOI: 10.1038/nsmb.2915     Document Type: Article

References (61)

1. Steller, H. Mechanisms and genes of cellular suicide. Science 267, 1445-1449 (1995).
2. Crawford, E.D. & Wells, J.A. Caspase substrates and cellular remodeling. Annu. Rev. Biochem. 80, 1055-1087 (2011).
3. Rudel, T. & Bokoch, G.M. Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science 276, 1571-1574 (1997).
4. Metzstein, M.M., Stanfield, G.M. & Horvitz, H.R. Genetics of programmed cell death in C. elegans: past, present and future. Trends Genet. 14, 410-416 (1998).
5. Nakagawa, A., Shi, Y., Kage-Nakadai, E., Mitani, S. & Xue, D. Caspase-dependent conversion of Dicer ribonuclease into a death-promoting deoxyribonuclease. Science 328, 327-334 (2010).
6. Breckenridge, D.G. et al. Caenorhabditis elegans drp-1 and fis-2 regulate distinct cell-death execution pathways downstream of ced-3 and independent of ced-9. Mol. Cell 31, 586-597 (2008).
7. Chen, Y.Z., Mapes, J., Lee, E.S., Skeen-Gaar, R.R. & Xue, D. Caspase-mediated activation of Caenorhabditis elegans CED-8 promotes apoptosis and phosphatidylserine externalization. Nat. Commun. 4, 2726 (2013).
8. Cully, M., You, H., Levine, A.J. & Mak, T.W. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat. Rev. Cancer 6, 184-192 (2006).
9. Luo, J., Manning, B.D. & Cantley, L.C. Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell 4, 257-262 (2003).
10. Staal, S.P., Hartley, J.W. & Rowe, W.P. Isolation of transforming murine leukemia viruses from mice with a high incidence of spontaneous lymphoma. Proc. Natl. Acad. Sci. USA 74, 3065-3067 (1977).
11. Li, J. et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943-1947 (1997).
12. Vivanco, I. & Sawyers, C.L. The phosphatidylinositol 3-Kinase-AKT pathway in human cancer. Nat. Rev. Cancer 2, 489-501 (2002).
13. Cho, H. et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBβ). Science 292, 1728-1731 (2001).
14. Hers, I., Vincent, E.E. & Tavare, J.M. Akt signalling in health and disease. Cell. Signal. 23, 1515-1527 (2011).
15. Finch, C.E. & Ruvkun, G. The genetics of aging. Annu. Rev. Genomics Hum. Genet. 2, 435-462 (2001).
16. Kenyon, C. The plasticity of aging: insights from long-lived mutants. Cell 120, 449-460 (2005).
17. Wolff, S. & Dillin, A. The trifecta of aging in Caenorhabditis elegans. Exp. Gerontol. 41, 894-903 (2006).
18. Kimura, K.D., Tissenbaum, H.A., Liu, Y. & Ruvkun, G. daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 277, 942-946 (1997).
19. Morris, J.Z., Tissenbaum, H.A. & Ruvkun, G. A phosphatidylinositol-3-OH kinase family member regulating longevity and diapause in Caenorhabditis elegans. Nature 382, 536-539 (1996).
20. Wolkow, C.A., Munoz, M.J., Riddle, D.L. & Ruvkun, G. Insulin receptor substrate and p55 orthologous adaptor proteins function in the Caenorhabditis elegans daf-2/insulin-like signaling pathway. J. Biol. Chem. 277, 49591-49597 (2002).
21. Paradis, S., Ailion, M., Toker, A., Thomas, J.H. & Ruvkun, G.A. PDK1 homolog is necessary and sufficient to transduce AGE-1 PI3 kinase signals that regulate diapause in Caenorhabditis elegans. Genes Dev. 13, 1438-1452 (1999).
22. Paradis, S. & Ruvkun, G. Caenorhabditis elegans Akt/PKB transduces insulin receptor-like signals from AGE-1 PI3 kinase to the DAF-16 transcription factor. Genes Dev. 12, 2488-2498 (1998).
23. Hertweck, M., Gobel, C. & Baumeister, R. C. elegans SGK-1 is the critical component in the Akt/PKB kinase complex to control stress response and life span. Dev. Cell 6, 577-588 (2004).
24. Lin, K., Dorman, J.B., Rodan, A. & Kenyon, C. daf-16: an HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans. Science 278, 1319-1322 (1997).
25. Ogg, S. et al. The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 389, 994-999 (1997).
26. Lee, R.Y., Hench, J. & Ruvkun, G. Regulation of C. elegans DAF-16 and its human ortholog FKHRL1 by the daf-2 insulin-like signaling pathway. Curr. Biol. 11, 1950-1957 (2001).
27. Lin, K., Hsin, H., Libina, N. & Kenyon, C. Regulation of the Caenorhabditis elegans longevity protein DAF-16 by insulin/IGF-1 and germline signaling. Nat. Genet. 28, 139-145 (2001).
28. Gil, E.B., Malone Link, E., Liu, L.X., Johnson, C.D. & Lees, J.A. Regulation of the insulin-like developmental pathway of Caenorhabditis elegans by a homolog of the PTEN tumor suppressor gene. Proc. Natl. Acad. Sci. USA 96, 2925-2930 (1999).
29. Mihaylova, V.T., Borland, C.Z., Manjarrez, L., Stern, M.J. & Sun, H. The PTEN tumor suppressor homolog in Caenorhabditis elegans regulates longevity and dauer formation in an insulin receptor-like signaling pathway. Proc. Natl. Acad. Sci. USA 96, 7427-7432 (1999).
30. Ogg, S. & Ruvkun, G. The C. elegans PTEN homolog, DAF-18, acts in the insulin receptor-like metabolic signaling pathway. Mol. Cell 2, 887-893 (1998).
31. Rouault, J.P. et al. Regulation of dauer larva development in Caenorhabditis elegans by daf-18, a homologue of the tumour suppressor PTEN. Curr. Biol. 9, 329-332 (1999).
32. Dorman, J.B., Albinder, B., Shroyer, T. & Kenyon, C. The age-1 and daf-2 genes function in a common pathway to control the lifespan of Caenorhabditis elegans. Genetics 141, 1399-1406 (1995).
33. Larsen, P.L., Albert, P.S. & Riddle, D.L. Genes that regulate both development and longevity in Caenorhabditis elegans. Genetics 139, 1567-1583 (1995).
34. Quevedo, C., Kaplan, D.R. & Derry, W.B. AKT-1 regulates DNA-damage-induced germline apoptosis in C. elegans. Curr. Biol. 17, 286-292 (2007).
35. Parrish, J. et al. Mitochondrial endonuclease G is important for apoptosis in C. elegans. Nature 412, 90-94 (2001).
36. Parrish, J.Z. & Xue, D. Functional genomic analysis of apoptotic DNA degradation in C. elegans. Mol. Cell 11, 987-996 (2003).
37. Stanfield, G.M. & Horvitz, H.R. The ced-8 gene controls the timing of programmed cell deaths in C. elegans. Mol. Cell 5, 423-433 (2000).
38. Kokel, D., Li, Y., Qin, J. & Xue, D. The nongenotoxic carcinogens naphthalene and para-dichlorobenzene suppress apoptosis in Caenorhabditis elegans. Nat. Chem. Biol. 2, 338-345 (2006).
39. Conradt, B. & Horvitz, H.R. The C. elegans protein EGL-1 is required for programmed cell death and interacts with the Bcl-2-like protein CED-9. Cell 93, 519-529 (1998).
40. Xue, D., Shaham, S. & Horvitz, H.R. The Caenorhabditis elegans cell-death protein CED-3 is a cysteine protease with substrate specificities similar to those of the human CPP32 protease. Genes Dev. 10, 1073-1083 (1996).
41. Park, W.S. et al. Comprehensive identification of PIP3-regulated PH domains from C. elegans to H. sapiens by model prediction and live imaging. Mol. Cell 30, 381-392 (2008).
42. Tullet, J.M. et al. Direct inhibition of the longevity-promoting factor SKN-1 by insulin-like signaling in C. elegans. Cell 132, 1025-1038 (2008).
43. Datta, S.R., Brunet, A. & Greenberg, M.E. Cellular survival: a play in three Akts. Genes Dev. 13, 2905-2927 (1999).
44. Isakoff, S.J. et al. Identification and analysis of PH domain-containing targets of phosphatidylinositol 3-kinase using a novel in vivo assay in yeast. EMBO J. 17, 5374-5387 (1998).
45. Parent, C.A., Blacklock, B.J., Froehlich, W.M., Murphy, D.B. & Devreotes, P.N. G protein signaling events are activated at the leading edge of chemotactic cells. Cell 95, 81-91 (1998).
46. Meili, R. et al. Chemoattractant-mediated transient activation and membrane localization of Akt/PKB is required for efficient chemotaxis to cAMP in Dictyostelium. EMBO J. 18, 2092-2105 (1999).
47. Servant, G. et al. Polarization of chemoattractant receptor signaling during neutrophil chemotaxis. Science 287, 1037-1040 (2000).
48. Fayard, E., Tintignac, L.A., Baudry, A. & Hemmings, B.A. Protein kinase B/Akt at a glance. J. Cell Sci. 118, 5675-5678 (2005).
49. Stambolic, V. et al. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95, 29-39 (1998).
50. Wu, X., Senechal, K., Neshat, M.S., Whang, Y.E. & Sawyers, C.L. The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Proc. Natl. Acad. Sci. USA 95, 15587-15591 (1998).
51. Kuo, Y.C. et al. Regulation of phosphorylation of Thr-308 of Akt, cell proliferation, and survival by the B55α regulatory subunit targeting of the protein phosphatase 2A holoenzyme to Akt. J. Biol. Chem. 283, 1882-1892 (2008).
52. Padmanabhan, S. et al. A PP2A regulatory subunit regulates C. elegans insulin/IGF-1 signaling by modulating AKT-1 phosphorylation. Cell 136, 939-951 (2009).
53. Gao, T., Furnari, F. & Newton, A.C. PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol. Cell 18, 13-24 (2005).
54. Brognard, J., Sierecki, E., Gao, T. & Newton, A.C. PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms. Mol. Cell 25, 917-931 (2007).
55. Cheng, G.Z. et al. Advances of AKT pathway in human oncogenesis and as a target for anti-cancer drug discovery. Curr. Cancer Drug Targets 8, 2-6 (2008).
56. Brenner, S. The genetics of Caenorhabditis elegans. Genetics 77, 71-94 (1974).
57. Wang, X. et al. C. elegans mitochondrial factor WAH-1 promotes phosphatidylserine externalization in apoptotic cells through phospholipid scramblase SCRM-1. Nat. Cell Biol. 9, 541-549 (2007).
58. Perrin, A.J. et al. Noncanonical control of C. elegans germline apoptosis by the insulin/IGF-1 and Ras/MAPK signaling pathways. Cell Death Differ. 20, 97-107 (2013).
59. Mello, C.C., Kramer, J.M., Stinchcomb, D. & Ambros, V. Efficient gene transfer in C.elegans: extrachromosomal maintenance and integration of transforming sequences. EMBO J. 10, 3959-3970 (1991).
60. Gu, T., Orita, S. & Han, M. Caenorhabditis elegans SUR-5, a novel but conserved protein, negatively regulates LET-60 Ras activity during vulval induction. Mol. Cell. Biol. 18, 4556-4564 (1998).
61. Tabara, H. et al. The rde-1 gene, RNA interference, and transposon silencing in C. elegans. Cell 99, 123-132 (1999).